Credit Suisse’s NEOPHOTONICS CORP NPTN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-95,076
| Closed | -$1.5M | – | 4536 |
|
|
2022
Q2 | $1.5M | Sell |
95,076
-29,446
| -24% | -$450K | ﹤0.01% | 2107 |
|
|
2022
Q1 | $1.89M | Sell |
124,522
-149,793
| -55% | -$2.28M | ﹤0.01% | 2118 |
|
|
2021
Q4 | $4.22M | Buy |
274,315
+244,040
| +806% | +$3.21M | ﹤0.01% | 2157 |
|
|
2021
Q3 | $265K | Buy |
30,275
+3,289
| +12% | +$30K | ﹤0.01% | 4132 |
|
|
2021
Q2 | $275K | Sell |
26,986
-4,829
| -15% | -$51K | ﹤0.01% | 4148 |
|
|
2021
Q1 | $380K | Sell |
31,815
-17,898
| -36% | -$203K | ﹤0.01% | 3912 |
|
|
2020
Q4 | $451K | Buy |
49,713
+17,295
| +53% | +$134K | ﹤0.01% | 3849 |
|
|
2020
Q3 | $197K | Buy |
32,418
+4,185
| +15% | +$31.9K | ﹤0.01% | 3831 |
|
|
2020
Q2 | $251K | Buy |
+28,233
| New | +$243K | ﹤0.01% | 3667 |
|
|
2020
Q1 | – | Sell |
-14,167
| Closed | -$125K | – | 4328 |
|
|
2019
Q4 | $125K | Buy |
+14,167
| New | +$106K | ﹤0.01% | 4053 |
|
|
2019
Q1 | – | Sell |
-17,899
| Closed | -$116K | – | 4200 |
|
|
2018
Q4 | $116K | Buy |
+17,899
| New | +$137K | ﹤0.01% | 3753 |
|
|
2018
Q2 | – | Sell |
-15,338
| Closed | -$105K | – | 4205 |
|
|
2018
Q1 | $105K | Buy |
15,338
+5,053
| +49% | +$32.1K | ﹤0.01% | 3794 |
|
|
2017
Q4 | $67K | Sell |
10,285
-24,919
| -71% | -$152K | ﹤0.01% | 3890 |
|
|
2017
Q3 | $195K | Buy |
35,204
+15,730
| +81% | +$106K | ﹤0.01% | 3938 |
|
|
2017
Q2 | $151K | Sell |
19,474
-2,813
| -13% | -$23.8K | ﹤0.01% | 3672 |
|
|
2017
Q1 | $201K | Sell |
22,287
-23,871
| -52% | -$249K | ﹤0.01% | 3621 |
|
|
2016
Q4 | $498K | Sell |
46,158
-39,814
| -46% | -$531K | ﹤0.01% | 3445 |
|
|
2016
Q3 | $1.4M | Buy |
85,972
+39,809
| +86% | +$560K | ﹤0.01% | 2661 |
|
|
2016
Q2 | $440K | Sell |
46,163
-10,396
| -18% | -$113K | ﹤0.01% | 3504 |
|
|
2016
Q1 | $794K | Buy |
56,559
+25,983
| +85% | +$269K | ﹤0.01% | 2896 |
|
|
2015
Q4 | $332K | Sell |
30,576
-1,824
| -6% | -$16.5K | ﹤0.01% | 3636 |
|
|
2015
Q3 | $220K | Sell |
32,400
-100,725
| -76% | -$780K | ﹤0.01% | 3888 |
|
|
2015
Q2 | $1.22M | Buy |
133,125
+99,546
| +296% | +$755K | ﹤0.01% | 2989 |
|
|
2015
Q1 | $227K | Buy |
+33,579
| New | +$135K | ﹤0.01% | 4010 |
|
|
2014
Q3 | – | Sell |
-47,220
| Closed | -$197K | – | 4713 |
|
|
2014
Q2 | $197K | Buy |
47,220
+23,081
| +96% | +$122K | ﹤0.01% | 4372 |
|
|
2014
Q1 | $191K | Sell |
24,139
-4,808
| -17% | -$35.8K | ﹤0.01% | 4369 |
|
|
2013
Q4 | $204K | Buy |
28,947
+2,647
| +10% | +$17.6K | ﹤0.01% | 4321 |
|
|
2013
Q3 | $195K | Buy |
26,300
+12,121
| +85% | +$94.3K | ﹤0.01% | 3975 |
|
|
2013
Q2 | $124K | Buy |
+14,179
| New | +$91.1K | ﹤0.01% | 3978 |
|
Other funds holding NPTN
Credit Suisse's NPTN Position: Q3 2022 in Review
Credit Suisse sold out of NEOPHOTONICS CORP (NPTN) in Q3 2022, closing a stake of 95,076 shares — an estimated $1.5M sold.
Credit Suisse first reported a position in NPTN in Q2 2013 and held it in 29 quarters. The position peaked at $4.22M in Q4 2021. 2 funds tracked by Wall St. Rank hold NPTN as of Q3 2022.
- Credit Suisse reported no remaining NEOPHOTONICS CORP position as of Q3 2022 after selling out during the quarter.
- Credit Suisse sold 95,076 NEOPHOTONICS CORP shares in Q3 2022, an estimated $1.5M.
- Credit Suisse first reported a position in NEOPHOTONICS CORP in Q2 2013 and held it in 29 quarters.
- Credit Suisse's NEOPHOTONICS CORP position peaked at $4.22M in Q4 2021.
- 2 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2022.
Based on Credit Suisse's 13F filing for Q3 2022, filed 10 Nov 2022.